0001437749-16-024538.txt : 20160202 0001437749-16-024538.hdr.sgml : 20160202 20160202171546 ACCESSION NUMBER: 0001437749-16-024538 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160129 FILED AS OF DATE: 20160202 DATE AS OF CHANGE: 20160202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALTHROP PATRICK J CENTRAL INDEX KEY: 0001284839 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 161381920 MAIL ADDRESS: STREET 1: 243 LEEDS COURT CITY: LAKE BLUFF STATE: IL ZIP: 60044 4 1 rdgdoc.xml FORM 4 X0306 4 2016-01-29 0001586049 Oxford Immunotec Global PLC OXFD 0001284839 BALTHROP PATRICK J C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 SHARE OPTION (RIGHT TO BUY) 11.62 2016-01-29 4 A 0 3728 0 A 2026-01-29 ORDINARY SHARES 3728 3728 D SHARE OPTION (RIGHT TO BUY) 11.62 2016-01-29 4 A 0 14914 0 A 2026-01-29 ORDINARY SHARES 14914 14914 D This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant. This option will vest and become exercisable as to one-third of the shares on each date on which the first three annual meetings of the issuer's shareholders are held after the date of grant. /s/ Elizabeth M. Keiley, as Attorney-in-Fact for Patrick J. Balthrop, Sr 2016-02-02